NCT03852784

Brief Summary

Osteoarticular infections at pneumococcal are rare, potentially serious and remain under diagnosed. They represent 3 at 10% of the arthritis septic in the literature. 190 cases have been published of 1965 at 2003. They represent 0.3% at 0.6% of the bacteraemia at Streptococcus peumoniae.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

February 21, 2019

Last Update Submit

September 21, 2023

Conditions

Bone and Joint Infection

Keywords

Bone and Joint InfectionStreptococcus peumoniae

Outcome Measures

Primary Outcomes (1)

  • Description and rate of bone or joint infection with S. pneumoniae

    Description of the type of infection due to S. pneumoniae : patients and type of implant, profile of the bacterium associated in the infection, medical and chirurgical treatment

    Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

Secondary Outcomes (1)

  • Rate of Treatment Failure

    Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

Study Arms (1)

Bone and joint infection with Streptococcus peumoniae

Patients having had an osteoarticular infection with Streptococcus peumoniae

Other: Bone and joint infection with Streptococcus peumoniae

Interventions

Bone and joint infection with Streptococcus peumoniaeOTHER

description of the osteoarticular infection with Streptococcus peumoniae

Bone and joint infection with Streptococcus peumoniae

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients having had a bone and joint infection with S pneumoniae, with or without device managed at the Croix-Rousse hospital

You may qualify if:

  • patients having had a bone and joint infection with S pneumoniae, with or without device.

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Lyon, 69004, France

Location

Related Links

Study Officials

  • Tristan Ferry, Md,PhD

    Hospices Civils de Lyon

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical reserach assistant

Study Record Dates

First Submitted

February 21, 2019

First Posted

February 25, 2019

Study Start

January 1, 2019

Primary Completion

March 1, 2019

Study Completion

April 1, 2020

Last Updated

September 22, 2023

Record last verified: 2023-09

Locations

FR(1)